Angiotensin II (Ang II) in the PVN augments the CSAR which is prevented by pretreatment with AT1 receptor antagonist losartan in rats with CHF caused by coronary artery ligation[1],[16]. The gene discussed is AGT; the disease is congestive heart failure.